Bioniz Therapeutics

United States
Glenwood City, Wisconsin, United States, 92618

Company profile

Bioniz Therapeutics company profile

Bioniz is an emerging biotechnology/drug development company focused on discovering small peptides and molecules for the treatment of autoimmune diseases and some forms of cancer. Bioniz mission is to complete proof of concept and preclinical studies of its lead technology and seek partners to conduct clinical trials for regulatory approval and commercialization. At Bioniz, they are committed to the discovery of novel molecules that enhance the lives of people across the globe. They perform our research with integrity and conscious, and bear in mind always our responsibility to the public health and their investors. It was founded in 2009 and headquartered in Irvine, California.

Business identity

Contact email
[email protected]
Phone number
(949)273-6000
Operating status
Closed
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2009-01-01, Year

Headquarters

Postal code
92618
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
3
Total equity funding
$14.3M
Last funding
Series A / $13M / 2016-08-01
Last equity funding
Series A / $13M
Investors
4
Lead investors
2
Founders
1
Articles
7
Exited on
2022-02-16

Founders and investors

Founders

Nazli Azimi

Lead investors

David PyottTakeda Ventures

Investors

Cota CapitalDavid PyottSignatures CapitalTakeda Ventures